News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Metabolic Pharmaceuticals (MBP.AX) Denies Soccer Players Were Part of Secret Drug Trial



7/29/2013 8:50:02 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

FOUR Essendon footballers reportedly part of a "secret drug trial" were not given any injections, according to the pharmaceutical company which owns AOD9604, a compound at the centre of the sports doping scandal. In an announcement today to the Australian Stock Exchange, Calzada Limited says it "categorically refutes" allegations published by Fairfax Media it was involved in deceiving Essendon players to take part in a clinical trial involving AOD9604. Metabolic confirmed it included in a patent application case notes taken by sports scientist Stephen Dank documenting his treatment of four Essendon players with the compound.

Help employers find you! Check out all the jobs and post your resume.

Read at The Australian
Read at News Release
Read at Ninemsn
Read at News Release
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES